Dimethoate (Rogor)

03/01/1993 - "The results obtained using a bolus dose were virtually identical to those from the trial with overtolerance peas, and indicated that dimethoate is readily absorbed and its urinary metabolites are readily eliminated following exposures to low doses (0.1 mg/kg body weight)."
09/30/2016 - "Furthermore, we performed a regression analysis with body weight and dimethoate toxicity. "
03/01/2012 - "Male Wistar rats were randomly divided into six groups of ten each: a control group (C), a group that received dimethoate (20 mg/kg body weight) (D), a group given Deglet Nour extract (DNE), a group treated with DNE 30 min before the administration of dimethoate (DNE + D), a group which received VitC (100 mg/kg body weight) plus dimethoate (Vit C + D), and a group given dimethoate for the first month and DNE 30 min after administration of dimethoate, during the second month (D + DNE). "
11/01/2007 - "The animals of the exposed groups were fed with laboratory chow combined with 2, 8 or 20 mg/kg body weight/day dimethoate for 90 consecutive days under controlled laboratory conditions. "
09/01/2005 - "There was a significant decrease in the body weight, ovaries and uterine weights in 28mg/(kg body weight day) dimethoate treatment for days 7 of pregnancy in mice as there was complete inhibition of implantations. "

11/01/2013 - "Protective effects of vitamin E and selenium against dimethoate-induced cardiotoxicity in vivo: biochemical and histological studies."
11/01/2013 - "The histopathological findings confirmed the biochemical results and the potential protective effects of selenium and vitamin E against cardiotoxicity induced by dimethoate."
11/01/2013 - "Our study investigated the potential ability of selenium and/or vitamin E, used as nutritional supplements, to alleviate cardiotoxicity induced by dimethoate. "

11/01/1992 - "The 9L gliosarcoma implanted intracranially and subcutaneously in the same animals was used as a preclinical model system to assess the efficacy of treatment combinations including: vincristine, CDDP, cyclo-phosphamide, etanidazole and radiation. "

04/15/2008 - "In this randomized multicenter study of 136 patients, 6 courses of CHOP (cyclo-phosphamide/doxorubicin/vincristine/prednisone) followed by rituximab (CHOP-R) were compared with rituximab-supplemented high-dose sequential chemotherapy with autografting (R-HDS) to assess the value of intensified chemo-therapy as a first-line treatment for high-risk follicular lymphoma (FL) after the introduction of monoclonal antibodies. "

01/01/2019 - "The use of nettle decoction as a treatment has significantly improved dimethoate induced behavioral and motor disorders."